Cypress Capital Group Vertex Pharmaceuticals Inc Transaction History

Cypress Capital Group

$879 Million
Q3 2024

A detailed history of Cypress Capital Group transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Cypress Capital Group holds 1,278 shares of VRTX stock, worth $522,395. This represents 0.07% of its overall portfolio holdings.

Number of Shares

1,278

Previous 1,365 6.37%

Holding current value

$522,395

Previous $639,000 7.04%

% of portfolio

0.07%

Previous 0.08%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$460.0 - $505.78 $40,020 - $44,002	-87 Reduced 6.37%	1,278 $594,000
Q2 2024 Jul 25, 2024	SELL	$392.81 - $485.53 $290,679 - $359,292	-740 Reduced 35.15%	1,365 $639,000
Q1 2024 May 08, 2024	SELL	$407.69 - $446.08 $134,130 - $146,760	-329 Reduced 13.52%	2,105 $879,000
Q4 2023 Jan 24, 2024	SELL	$343.0 - $410.68 $83,349 - $99,795	-243 Reduced 9.08%	2,434 $990,000
Q3 2023 Nov 02, 2023	SELL	$338.18 - $362.46 $12,174 - $13,048	-36 Reduced 1.33%	2,677 $930,000
Q2 2023 Jul 26, 2023	BUY	$314.42 - $351.91 $258,138 - $288,918	821 Added 43.39%	2,713 $954,000
Q1 2023 May 04, 2023	SELL	$283.23 - $323.1 $16,427 - $18,739	-58 Reduced 2.97%	1,892 $596,000
Q4 2022 Feb 14, 2023	BUY	$285.76 - $321.48 $185,458 - $208,640	649 Added 49.88%	1,950 $563,000
Q3 2022 Nov 04, 2022	BUY	$273.83 - $305.53 $139,653 - $155,820	510 Added 64.48%	1,301 $377,000
Q1 2022 May 16, 2022	SELL	$221.42 - $260.97 $195,292 - $230,175	-882 Reduced 52.72%	791 $207,000
Q4 2021 Feb 15, 2022	SELL	$177.01 - $223.45 $294,367 - $371,597	-1,663 Reduced 49.85%	1,673 $367,000
Q3 2021 Oct 12, 2021	SELL	$181.39 - $202.99 $58,407 - $65,362	-322 Reduced 8.8%	3,336 $605,000
Q2 2021 Jul 13, 2021	SELL	$187.49 - $221.1 $121,681 - $143,493	-649 Reduced 15.07%	3,658 $738,000
Q1 2021 Apr 14, 2021	SELL	$207.02 - $241.31 $282,375 - $329,146	-1,364 Reduced 24.05%	4,307 $926,000
Q4 2020 Jan 12, 2021	SELL	$207.01 - $276.09 $364,544 - $486,194	-1,761 Reduced 23.69%	5,671 $1.34 Million
Q3 2020 Oct 08, 2020	BUY	$255.65 - $303.1 $487,524 - $578,011	1,907 Added 34.52%	7,432 $2.02 Million
Q2 2020 Jul 10, 2020	BUY	$225.48 - $295.8 $1.03 Million - $1.35 Million	4,567 Added 476.72%	5,525 $1.6 Million
Q4 2019 Jan 10, 2020	BUY	$166.71 - $223.91 $159,708 - $214,505	958 New	958 $210,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cypress Capital Group, based on Form 13F filings with the SEC.

News

Stay updated on Cypress Capital Group with notifications on news.

Account

Cypress Capital Group Vertex Pharmaceuticals Inc Transaction History